XTL BIOPHARMACEUTICALS LTD
XTLBCIK 0001023549
Revenue (TTM)
$451K
FY Dec 2024
Net Income (TTM)
−$1.03M
+42.4% YoY
FY Dec 2024
EPS Diluted (TTM)
−$0.00
0.0% YoY
FY Dec 2024
Gross Margin
0.7%
FY Dec 2024
Operating Margin
-481.6%
FY Dec 2024
Net Margin
-227.7%
FY Dec 2024
Free Cash Flow (TTM)
—
FY Dec 2024
Cash
$371K
FY Dec 2024
Total Debt
—
FY Dec 2024
Shares Outstanding
881.39M sh
FY Dec 2024
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.